Differential Efficacy of Supportive and Interpretative Psychodynamic Techniques for Dependent and Self-critical Depressive Patients
PsychodynDep
1 other identifier
interventional
120
1 country
1
Brief Summary
Post-hoc analysis of psychotherapy outcome data suggest that psychodynamic techniques for Major Depressive Disorder are differentially efficacious dependent on personality traits of the patient. More specifically, supportive techniques are hypothesized to be more efficacious for dependent patients, interpretative techniques to be more efficacious for self-critical patients, and mixed supportive/interpretative techniques to be more efficacious for mixed dependent/self-critical patients. Moreover, supportive techniques are hypothesized to impact on depressive symptoms through increased relational capacities while interpretative techniques impact through increased self-understanding. These hypotheses are tested in an experimental single case design with three dependent, three self-critical and three mixed dependent/self-critical depressive patients. These patients go through a time-limited (50 sessions) experimental treatment which exists of a sequence of four A phases (control conditions), one B phase (supportive techniques only), one C phase (interpretative techniques only), and one BC phase (mixed supportive/interpretative techniques).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable major-depressive-disorder
Started Dec 2012
Typical duration for not_applicable major-depressive-disorder
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 5, 2012
CompletedFirst Posted
Study publicly available on registry
July 13, 2012
CompletedStudy Start
First participant enrolled
December 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedDecember 1, 2021
November 1, 2021
3 years
July 5, 2012
November 18, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Reduction in depressive symptoms at 25 weeks (50 sessions, 2 sessions/week).
•Measures each session: The BDI-II with adapted instructions is used to measure depressive symptoms. The process variables associated with change in depressive symptoms will be studied in an exploratory way by means of Psychotherapy Process Q Set (PQS) ratings of the transcripts of the sessions. •Measures during A phases: Besides the SCID-I (session 1 and 2 of each A phase) and SCID-II (session 3 of each A phase) interviews, the therapist will administer the Depressive Experiences Questionnaire (DEQ).
25 weeks
Secondary Outcomes (3)
improvement in relational capacities
25 weeks
improvement in insight
25 weeks
improvement in quality of life, a broad range of physical and psychological symptoms.
25 weeks
Study Arms (3)
supportive
ACTIVE COMPARATORinterpretative
ACTIVE COMPARATORmixed supportive/interpretative
ACTIVE COMPARATORInterventions
the patients go through a time-limited (50 sessions, 45 minutes, 2 sessions/week) experimental treatment which exists of a sequence of four A phases (control conditions), one B phase (supportive techniques only), one C phase (interpretative techniques only), and one BC phase (mixed supportive/interpretative techniques).
Eligibility Criteria
You may qualify if:
- Patient meets criteria for Major Depressive Disorder (as assessed by SCID-I and DSM-IV-TR)
- Patient is prepared to give informed consent
You may not qualify if:
- Patient uses antidepressant medication during the treatment
- Patient scores 3 on the suicide item of the BDI-II
- Patient meets criteria for psychotic or personality disorder (as assessed by SCID-II)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Ghentlead
- Funding by BOF (Bijzonder Onderzoeksfonds)collaborator
Study Sites (1)
Ghent University
Ghent, 9000, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stijn Vanheule, Prof Phd
University Ghent
- PRINCIPAL INVESTIGATOR
Gilbert Lemmens, Phd MD
University Hospital, Ghent
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 5, 2012
First Posted
July 13, 2012
Study Start
December 1, 2012
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
December 1, 2021
Record last verified: 2021-11